Yield10 bioscience, inc. (YTEN)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue:
Revenue

179

140

224

318

124

135

76

285

60

-

223

293

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue from termination of ADM collaboration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

38,885

-

-

-

-

-

-

Product revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

113

72

118

115

211

102

-1,190

39

822

790

-181

70

373

14

-

-

-

-

-

-

Grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

324

341

473

188

157

101

327

470

452

506

390

463

448

609

563

584

724

556

576

461

378

351

443

99

25

21

5

License fee and royalty revenue from related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26

92

301

25

42

Research and development revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

238

380

-

-

-

-

-

-

-

-

-

62

License fee and royalty revenue (Note 12)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

161

121

232

127

25

63

81

27

62

49

87

28

89

45

-

-

-

-

-

-

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

324

341

473

188

157

-366

327

744

645

856

632

699

613

-500

629

1,706

1,943

462

674

923

39,322

439

469

191

326

46

109

Expenses:
Cost of product revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

90

84

110

786

420

166

25

130

1,196

557

222

316

437

55

-

-

-

-

-

-

Research and development

1,460

1,202

1,232

1,191

1,223

1,087

1,335

1,260

1,101

1,218

1,132

1,138

1,109

1,148

1,547

1,547

1,428

-3,306

1,664

4,319

3,925

4,062

4,088

4,380

4,812

4,483

4,515

4,945

4,859

7,195

4,931

5,006

6,045

6,093

6,153

6,000

6,199

5,906

5,838

General and administrative

1,387

1,353

990

1,025

1,186

943

1,417

1,456

1,276

1,415

1,073

1,866

1,276

786

1,530

1,149

2,272

518

1,769

2,464

2,466

2,536

2,472

2,665

3,132

2,401

2,473

3,422

3,312

2,239

3,170

3,437

4,399

3,963

3,895

4,196

3,787

4,161

3,848

Total expenses

2,847

2,555

2,222

2,216

2,409

2,030

2,752

2,716

2,377

2,633

2,205

3,004

2,385

1,934

3,077

2,696

3,700

-2,962

3,433

6,873

6,475

6,708

7,346

7,465

8,110

6,909

7,118

9,563

8,728

9,656

8,417

8,880

10,499

10,056

10,048

10,196

9,986

10,067

9,686

Loss from operations

-2,668

-2,415

-1,998

-1,898

-2,285

-1,895

-2,676

-2,431

-2,317

-2,529

-1,982

-2,711

-2,061

-1,593

-2,604

-2,508

-3,543

2,596

-3,106

-6,129

-5,830

-5,852

-6,714

-6,766

-7,497

-7,409

-6,489

-7,857

-6,785

-9,194

-7,743

-7,957

28,823

-9,617

-9,579

-10,005

-9,660

-10,021

-9,577

Interest income, net

-

-

-

-

-

-

-

-

-

-

2

2

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense, net

-

-

-

-

-

-

-

-

-

-

45

18

32

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense):
Fair Value Adjustment of Warrants

957

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

37

-

-

-

27

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

1

1

1

4

-3

5

25

4

12

10

46

27

34

17

94

19

23

20

30

34

Other income (expense), net

-4

-20

16

27

-2

-125

38

38

25

-23

-43

-16

-31

-

-

-

-

-12

0

55

-14

44

2

7

1

-33

-13

-21

12

-

-29

-25

-

-

-

-

-

-

-

Total other income (expense)

-924

-

-

-

25

-

-

-

-

-

-

-

-

-

-8

1

3

-

1

56

-13

45

6

4

6

-8

-9

-9

22

-

-2

9

-

-

-

-

-

-

-

Net loss from operations before income tax expense

-3,592

-

-

-

-2,260

-

-

-

-

-

-

-

-

-

-2,612

-

-

-

-3,105

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax expense

8

-

-

-

0

-

-

-

-

-

-

-

-

-

-1,042

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,572

-1,570

-2,507

-3,540

-

-3,105

-

-

-5,807

-6,708

-6,762

-7,491

-

-6,498

-

-

-

-

-

-

-

-

-

-

-

-

Income from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-522

6,853

-691

-2,958

-

-2,743

-

-

-448

-294

-473

-663

-

-753

-

-

-

-

-

-

-

-

-

-

-

-

Income tax provision

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,259

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from write down of assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

891

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total net income from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-360

5,594

-691

-2,958

-

-2,743

-

-

-445

-1,185

-473

-663

-

-753

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-3,600

-

-

-

-2,260

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-3,600

-

-

-

-2,260

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Available to Common Stockholders, Basic

-

-

-1,982

-1,871

-

-

-2,638

-2,393

-2,292

-3,979

-2,025

-2,727

-2,092

-1,932

4,024

-3,198

-6,498

-

-5,848

-6,073

-5,843

-

-7,893

-7,235

-8,154

-

-7,251

-7,866

-6,763

-9,517

-7,745

-7,948

28,840

-9,603

-9,560

-9,982

-9,640

-9,991

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9,543

Net loss per share (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.23

-0.20

-0.27

-0.23

-0.23

0.84

-0.27

-0.28

-0.33

-0.36

-

-0.36

Net loss from continuing operations (in USD per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.56

-0.90

-0.13

-

-0.12

-

-

-

-0.71

-1.16

-0.21

-

-0.19

-

-

-

-

-

-

-

-

-

-

-

-

Net loss from discontinued operations (in USD per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2.00

-0.25

-0.11

-

-0.10

-

-

-

-0.13

-0.08

-0.02

-

-0.02

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net loss per share (in USD per share)

-2.12

-26.58

-0.16

-0.15

-8.61

-36.25

-0.26

-0.24

-0.24

-1.00

-0.59

-0.96

-0.74

-

1.44

-1.15

-0.24

-

-0.22

-0.26

-0.26

-

-0.84

-1.24

-0.23

-

-0.21

-

-

-

-

-

-

-

-

-

-

-0.37

-

Net income (loss) per share, Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.23

-0.20

-0.27

-0.23

-0.23

0.84

-0.27

-0.28

-0.33

-0.36

-

-0.36

Number of shares used in per share calculations:
Basic and diluted (in shares)

1,697

-23,815

12,518

12,494

262

-28,707

10,010

9,991

9,698

4,054

3,410

2,849

2,839

-21,801

2,786

2,771

27,367

27,375

26,979

23,117

22,556

-9,049

9,381

5,831

34,806

-

34,516

-

-

-

-

-

-

-

-

-

-

-

-

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34,434

34,353

34,305

34,243

34,183

34,136

34,220

34,080

29,824

26,904

26,880

26,780

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34,434

34,353

34,425

34,243

34,183

34,265

34,220

34,080

29,824

26,904

26,880

26,780

Grant
Revenue

179

140

224

318

124

135

76

285

60

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-